secwatch.observer — SEC 8-K summary
======================================

Issuer:     Scilex Holding Co (SCLX)
CIK:        0001820190
Form:       8-K
Filed at:   2024-10-28T23:59:59+00:00
Accession:  0000950170-24-117557
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Scilex declares preferred stock dividend exchangeable for up to 10% of Semnur ownership; record date Nov 7
--------------------------------------------------------------------------------

- Board declared 5M shares of Series 1 Mandatory Exchangeable Preferred Stock, payable by Jan 6, 2025 to holders of record Nov 7, 2024.
- Each preferred share will be exchanged for a pro-rata portion of up to 10% of Scilex's interest in Semnur after the Denali merger.
- Business combination with Denali Capital Acquisition Corp. (DECA) expected to close by Q1 2025; Semnur valued at $2.5B pre-transaction.
- Syneos Health Consulting projects peak annual sales of $3.6B for SP-102 (SEMDEXA) by 5th year post-launch.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1820190/000095017024117557/0000950170-24-117557-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1820190/000095017024117557/sclx-20241027.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-117557

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer